Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Depreciation & Amortization (CF): 2020-2024

Historic Depreciation & Amortization (CF) for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to $1.0 million.

  • Candel Therapeutics' Depreciation & Amortization (CF) rose 62.36% to $289,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $955,000, marking a year-over-year increase of 30.82%. This contributed to the annual value of $1.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • Candel Therapeutics' Depreciation & Amortization (CF) amounted to $1.0 million in FY2024, which was down 0.00% from $1.0 million recorded in FY2023.
  • In the past 5 years, Candel Therapeutics' Depreciation & Amortization (CF) ranged from a high of $1.0 million in FY2023 and a low of $91,000 during FY2020.
  • For the 3-year period, Candel Therapeutics' Depreciation & Amortization (CF) averaged around $926,000, with its median value being $1.0 million (2024).
  • Data for Candel Therapeutics' Depreciation & Amortization (CF) shows a peak YoY skyrocketed of 235.34% (in 2022) over the last 5 years.
  • Over the past 5 years, Candel Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $91,000 in 2020, then surged by 154.95% to $232,000 in 2021, then spiked by 235.34% to $778,000 in 2022, then increased by 28.53% to $1.0 million in 2023, then remained steady at $1.0 million in 2024.